Zobrazeno 1 - 10
of 23
pro vyhledávání: '"C. M. Gamboa-Alonso"'
Autor:
C. M. Gamboa-Alonso, A. Moreno-Salinas, L. Santoyo-Fexas, G. Figueroa-Parra, D. Á. Galarza-Delgado, Ana Laura De Leon-Ibarra, Jorge A. Esquivel-Valerio
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Patients with rheumatic diseases (RD) have a higher risk of morbidity and mortality from vaccine-preventable infections attributed to disease activity, comorbidities, immunosuppressive therapy, and other factors. Vaccines are one of the safest and mo
Publikováno v:
Annals of the Rheumatic Diseases
We thank Zhang et al for the interest showed in our letter1 and appreciate their comments about the care of rheumatic patients during the COVID-19 pandemic.2 We agree that the function of all rheumatology outpatient clinics around the world has chang
Publikováno v:
Annals of the Rheumatic Diseases
We thank Xie et al 1 for the interest in our letter2 and found some relevant points to discuss the role of antimalarial drugs during the COVID-19 pandemic. The information has increased at an incredible rate since our letter was published. Despite in
Autor:
Adrián Camacho-Ortiz, G. Figueroa-Parra, Dionicio Ángel Galarza-Delgado, C. M. Gamboa-Alonso, Gloria Mayela Aguirre-García
Publikováno v:
Annals of the Rheumatic Diseases
According to the last WHO situation report (10 March 2020), the novel Coronavirus disease 2019 (COVID-19) has been confirmed in 113 702 patients, most of them in China (71.1%) and the rest in other 109 countries, with a global case-fatality rate (CFR
Autor:
C. M. Gamboa-Alonso, José Carlos Jaime-Pérez, David Gómez-Almaguer, Mónica Andrea Pinzón-Uresti, Leslie Jazmín López-Silva, Andrés Gómez-De León, Raúl Alberto Jiménez-Castillo
Publikováno v:
Blood Cells, Molecules, and Diseases. 63:27-31
There is scarce information regarding the concentration of cytokines in cerebrospinal fluid (CSF) of children with acute lymphoblastic leukemia (ALL) and their clinical association with CNS status. A prospective analysis of 40 patients18years with ne
Autor:
C. M. Gamboa-Alonso, G. Figueroa-Parra, A. L. De-Leon-Ibarra, D. Á. Galarza-Delgado, E. Barriga-Maldonado, C. M. Skinner Taylor, C. A. Cavazos-Cavazos
Publikováno v:
Annals of the Rheumatic Diseases. 79:1190-1191
Background:Osteoporosis (OP) is characterized by compromised bone strength and deterioration of quality, often leading to fragility fractures (1). Dual-energy x-ray absorptiometry (DXA) is the recommended test for OP screening among patients with rhe
Publikováno v:
Annals of the rheumatic diseases. 79(9)
Recently, the journal published the 2019 update of the European League Against Rheumatism (EULAR) recommendations for the management of systemic lupus erythematosus (SLE)1 that we reviewed with great interest. It drew our attention that the lack of m
Autor:
C. M. Gamboa-Alonso, Miguel Ángel Villarreal-Alarcón, David Vega-Morales, A. L. De-Leon-Ibarra, D. Á. Galarza-Delgado, Jazzia Emily Diaz-Angulo, G. Figueroa-Parra
Publikováno v:
Annals of the Rheumatic Diseases. 80:1166.2-1167
Background:Systemic Lupus Erythematosus (SLE) is a heterogeneous chronic multisystemic disease that has an increased risk of requiring inpatient management with higher morbidity and mortality rates.The most frequent causes of mortality are a high dis
Autor:
Miguel Ángel Villarreal-Alarcón, C. M. Gamboa-Alonso, G. Figueroa-Parra, D. Á. Galarza-Delgado, A. Moreno-Salinas
Publikováno v:
Annals of the Rheumatic Diseases. 80:1031.1-1032
Background:Dermatological manifestations are not rare in patients with rheumatic diseases (RD). Multidisciplinary management and direct interaction between these disciplines are essential. According to Dermatology-Rheumatology clinics, most diagnoses
Autor:
A. Y. Lujano Negrete, C. M. Gamboa-Alonso, C. M. Skinner Taylor, R. Moyeda Martinez, G. Figueroa-Parra, D. Á. Galarza-Delgado
Publikováno v:
Annals of the Rheumatic Diseases. 80:1345.3-1346
Background:Osteoporosis (OP) is characterized by compromised bone strength and deterioration of quality, often leading to fragility fractures(1). Dual-energy x-ray absorptiometry (DXA) is the recommended test for OP screening(1). However, there are l